Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Important safety information: Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The decision about which weight loss option is appropriate should always be made in partnership with your doctor, who will consider several important factors, including: Your overall health Medical history Current medications The amount of weight youre aiming to lose Your tolerance for certain treatments Always talk with your doctor when exploring effective weight loss options
Phase 3 Trial Results and Pivotal Evidence TRIUMPH-1 is a phase 3 obesity trial, and Lilly reported that 45.3% of participants receiving 12 mg achieved at least 30% body-weight reduction at 80 weeks [7]
doi: 10.1016/j.cgh.2020.10.045
While some patients report virtually no sensation, others may experience mild stinging or burning, particularly during initial injections
As a practice we value the best interest of our guests and offer DUAL peptide medication as a medical weight loss option as we want guests who make this investment to get the best performing option available
US$ 20.01
US$ 22.78
US$ 27.02
US$ 26.11
US$ 28.63
US$ 21.94
US$ 24.81
